U.S., Dec. 5 -- ClinicalTrials.gov registry received information related to the study (NCT07263295) titled 'Evaluation of Diaphragmatic Function After Interscalene Block With Liposomal Bupivacaine' on Sept. 27.
Brief Summary: The study aims to evaluation the effects of Liposomal Bupivacaine on diaphragmatic function in patients undergoing upper limb surgery who receive Interscalene Brachial Plexus Block. A total of 120 eligible patients will be enrolled and divided into two groups: Group A will receive 20ml of 0.5% Hydrochloride Bupivacaine , while Group B will receive 10ml of 0.5% Hydrochloride Bupivacaine plus 10ml of Liposomal Bupivacaine. Assessments of diaphragmatic function, pulmonary function, and pain intensity will be performed be...